Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 963155

Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models


Juretić, Marina; Cetina-Čižmek, Biserka; Filipović-Grčić, Jelena; Hafner, Anita; Lovrić, Jasmina; Pepić, Ivan
Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models // European Journal of Pharmaceutical Sciences, 120 (2018), 133-141 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 963155 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models

Autori
Juretić, Marina ; Cetina-Čižmek, Biserka ; Filipović-Grčić, Jelena ; Hafner, Anita ; Lovrić, Jasmina ; Pepić, Ivan

Izvornik
European Journal of Pharmaceutical Sciences (0928-0987) 120 (2018); 133-141

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Drug permeability ; In vitro and ex vivo corneal models ; HCE-T ; Surfactants ; Self-aggregation

Sažetak
The objective of this study was to systematically investigate the effects of surface active ophthalmic excipients on the corneal permeation of ophthalmic drugs using in vitro (HCE-T cell-based model) and ex vivo (freshly excised porcine cornea) models. The permeation of four ophthalmic drugs (i.e., timolol maleate, chloramphenicol, diclofenac sodium and dexamethasone) across in vitro and ex vivo corneal models was evaluated in the absence and presence of four commonly used surface active ophthalmic excipients (i.e., olysorbate 80, Tyloxapol, Cremophor® EL and Pluronic® F68). The concentration and self- aggregation-dependent effects of surface active ophthalmic excipients on ophthalmic drug permeability were studied from the concentration region where only dissolved monomer molecules of surface active ophthalmic excipients exist, as well as the concentration region in which aggregates of variable size and dispersion are spontaneously formed. Neither the surface active ophthalmic excipients nor the ophthalmic drugs at all concentrations that were tested significantly affected the barrier properties of both corneal models, as assessed by transepithelial electrical resistance (TEER) monitoring during the permeability experiments. The lowest concentration of all investigated surface active ophthalmic excipients did not significantly affect the ophthalmic drug permeability across both of the corneal models that were used. For three ophthalmic drugs (i.e., chloramphenicol, diclofenac sodium and dexamethasone), depressed in vitro and ex vivo permeability were observed in the concentration range of either Polysorbate 80, Tyloxapol, Cremophor® EL or Pluronic® F68, at which self- aggregation is detected. The effect was the most pronounced for Cremophor® EL (1 and 2%, w/V) and was the least pronounced for Pluronic® F68 (1%, w/V). However, all surface active ophthalmic excipients over the entire concentration range that was tested did not significantly affect the in vitro and ex vivo permeability of timolol maleate, which is the most hydrophilic ophthalmic drug that was investigated. The results of the dynamic light scattering measurements point to the association of ophthalmic drugs with self- aggregates of surface active ophthalmic excipients as the potential mechanism of the observed permeability-depressing effect of surface active ophthalmic excipients. A strong and statistically significant correlation was observed between in vitro and ex vivo permeability of ophthalmic drugs in the presence of surface active ophthalmic excipients, which indicates that the observed permeability-altering effects of surface active ophthalmic excipients were comparable and were mediated by the same mechanism in both corneal models.

Izvorni jezik
Engleski

Znanstvena područja
Farmacija



POVEZANOST RADA


Projekti:
HRZZ-PA-04.01/56

Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb


Citiraj ovu publikaciju:

Juretić, Marina; Cetina-Čižmek, Biserka; Filipović-Grčić, Jelena; Hafner, Anita; Lovrić, Jasmina; Pepić, Ivan
Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models // European Journal of Pharmaceutical Sciences, 120 (2018), 133-141 (međunarodna recenzija, članak, znanstveni)
Juretić, M., Cetina-Čižmek, B., Filipović-Grčić, J., Hafner, A., Lovrić, J. & Pepić, I. (2018) Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models. European Journal of Pharmaceutical Sciences, 120, 133-141.
@article{article, author = {Jureti\'{c}, Marina and Cetina-\v{C}i\v{z}mek, Biserka and Filipovi\'{c}-Gr\v{c}i\'{c}, Jelena and Hafner, Anita and Lovri\'{c}, Jasmina and Pepi\'{c}, Ivan}, year = {2018}, pages = {133-141}, keywords = {Drug permeability, In vitro and ex vivo corneal models, HCE-T, Surfactants, Self-aggregation}, journal = {European Journal of Pharmaceutical Sciences}, volume = {120}, issn = {0928-0987}, title = {Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models}, keyword = {Drug permeability, In vitro and ex vivo corneal models, HCE-T, Surfactants, Self-aggregation} }
@article{article, author = {Jureti\'{c}, Marina and Cetina-\v{C}i\v{z}mek, Biserka and Filipovi\'{c}-Gr\v{c}i\'{c}, Jelena and Hafner, Anita and Lovri\'{c}, Jasmina and Pepi\'{c}, Ivan}, year = {2018}, pages = {133-141}, keywords = {Drug permeability, In vitro and ex vivo corneal models, HCE-T, Surfactants, Self-aggregation}, journal = {European Journal of Pharmaceutical Sciences}, volume = {120}, issn = {0928-0987}, title = {Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models}, keyword = {Drug permeability, In vitro and ex vivo corneal models, HCE-T, Surfactants, Self-aggregation} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font